Health
Study links metformin to slowed cognitive decline – Australian Hospital + Healthcare Bulletin
A study of older Australians with type 2 diabetes revealed that taking metformin resulted in slower cognitive decline with lower dementia rates than those who d…
Used by millions of people across the globe to optimise blood glucose levels, metformin is regarded as the first-line treatment for most cases of type 2 diabetes.
A six-year study of older Australians with type 2 diabetes has revealed that those taking metformin experienced slower cognitive decline with lower dementia rates than those who did not use the medication.
Led by researchers at the Garvan Institute of Medical Research and the Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney, the …
-
Business5 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General23 hours agoFederal Labor makes $100m Canberra convention centre funding pledge for planning, new aquatic centre
-
Noosa News22 hours agoHomicide investigation launched into stabbing death of 39-year-old Brisbane man at Bowen Hills apartment
-
General16 hours agoAlbo and Dutton do battle for the Port of Darwin